Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 120

1.

Study Design and Evaluation of Risk Minimization Measures: A Review of Studies Submitted to the European Medicines Agency for Cardiovascular, Endocrinology, and Metabolic Drugs.

Mazzaglia G, Straus SMJ, Arlett P, da Silva D, Janssen H, Raine J, Alteri E.

Drug Saf. 2018 Feb;41(2):191-202. doi: 10.1007/s40264-017-0604-4.

2.

Use of azithromycin and risk of ventricular arrhythmia.

Trifirò G, de Ridder M, Sultana J, Oteri A, Rijnbeek P, Pecchioli S, Mazzaglia G, Bezemer I, Garbe E, Schink T, Poluzzi E, Frøslev T, Molokhia M, Diemberger I, Sturkenboom MCJM.

CMAJ. 2017 Apr 18;189(15):E560-E568. doi: 10.1503/cmaj.160355.

3.

Erratum to: Assessing risk of osteoporotic fractures in primary care: development and validation of the FRA-HS algorithm.

Lapi F, Bianchini E, Michieli R, Pasqua A, Cricelli I, Mazzaglia G, Frediani B, Prieto-Alhambra D, Brandi ML, Cricelli C.

Calcif Tissue Int. 2017 Jun;100(6):550. doi: 10.1007/s00223-017-0262-7. No abstract available.

PMID:
28289801
4.

Antibiotic-Induced Liver Injury in Paediatric Outpatients: A Case-Control Study in Primary Care Databases.

Ferrajolo C, Verhamme KM, Trifirò G, 't Jong GW, Picelli G, Giaquinto C, Mazzaglia G, Stricker BH, Rossi F, Capuano A, Sturkenboom MC.

Drug Saf. 2017 Apr;40(4):305-315. doi: 10.1007/s40264-016-0493-y.

5.

Drug-induced progressive multifocal leukoencephalopathy in multiple sclerosis: European regulators' perspective.

Anton R, Haas M, Arlett P, Weise M, Balabanov P, Mazzaglia G, Prieto L, Keller-Stanislawski B, Raine J.

Clin Pharmacol Ther. 2017 Aug;102(2):283-289. doi: 10.1002/cpt.604. Epub 2017 Jan 23. Review.

PMID:
28001298
6.

Automatic identification of type 2 diabetes, hypertension, ischaemic heart disease, heart failure and their levels of severity from Italian General Practitioners' electronic medical records: a validation study.

Gini R, Schuemie MJ, Mazzaglia G, Lapi F, Francesconi P, Pasqua A, Bianchini E, Montalbano C, Roberto G, Barletta V, Cricelli I, Cricelli C, Dal Co G, Bellentani M, Sturkenboom M, Klazinga N.

BMJ Open. 2016 Dec 9;6(12):e012413. doi: 10.1136/bmjopen-2016-012413.

7.

In vivo monitoring of topical therapy for acne with reflectance confocal microscopy.

Manfredini M, Greco M, Farnetani F, Mazzaglia G, Ciardo S, Bettoli V, Virgili A, Pellacani G.

Skin Res Technol. 2017 Feb;23(1):36-40. doi: 10.1111/srt.12298. Epub 2016 Jun 8.

PMID:
27273850
8.

Prescribing pattern of antipsychotic drugs during the years 1996-2010: a population-based database study in Europe with a focus on torsadogenic drugs.

Oteri A, Mazzaglia G, Pecchioli S, Molokhia M, Ulrichsen SP, Pedersen L, Poluzzi E, De Ponti F, Garbe E, Schink T, Herings R, Bezemer ID, Sturkenboom MC, Trifirò G.

Br J Clin Pharmacol. 2016 Aug;82(2):487-97. doi: 10.1111/bcp.12955. Epub 2016 May 18. Erratum in: Br J Clin Pharmacol. 2017 Jun;83(6):1360.

9.

Development and Validation of a Score for Adjusting Health Care Costs in General Practice.

Lapi F, Bianchini E, Cricelli I, Trifirò G, Mazzaglia G, Cricelli C.

Value Health. 2015 Sep;18(6):884-95. doi: 10.1016/j.jval.2015.05.004. Epub 2015 Jul 17.

10.

Useful Interplay Between Spontaneous ADR Reports and Electronic Healthcare Records in Signal Detection.

Pacurariu AC, Straus SM, Trifirò G, Schuemie MJ, Gini R, Herings R, Mazzaglia G, Picelli G, Scotti L, Pedersen L, Arlett P, van der Lei J, Sturkenboom MC, Coloma PM.

Drug Saf. 2015 Dec;38(12):1201-10. doi: 10.1007/s40264-015-0341-5.

11.

Risk of atrial fibrillation among bisphosphonate users: a multicenter, population-based, Italian study.

Herrera L, Leal I, Lapi F, Schuemie M, Arcoraci V, Cipriani F, Sessa E, Vaccheri A, Piccinni C, Staniscia T, Vestri A, Di Bari M, Corrao G, Zambon A, Gregori D, Carle F, Sturkenboom M, Mazzaglia G, Trifiro G.

Osteoporos Int. 2015 May;26(5):1499-506. doi: 10.1007/s00198-014-3020-y. Epub 2015 Mar 10.

12.

The role of electronic healthcare record databases in paediatric drug safety surveillance: a retrospective cohort study.

de Bie S, Coloma PM, Ferrajolo C, Verhamme KM, Trifirò G, Schuemie MJ, Straus SM, Gini R, Herings R, Mazzaglia G, Picelli G, Ghirardi A, Pedersen L, Stricker BH, van der Lei J, Sturkenboom MC; EU-ADR consortium.

Br J Clin Pharmacol. 2015 Aug;80(2):304-14. doi: 10.1111/bcp.12610. Epub 2015 May 20.

13.

Using real-world healthcare data for pharmacovigilance signal detection - the experience of the EU-ADR project.

Patadia VK, Coloma P, Schuemie MJ, Herings R, Gini R, Mazzaglia G, Picelli G, Fornari C, Pedersen L, van der Lei J, Sturkenboom M, Trifirò G; EU-ADR consortium.

Expert Rev Clin Pharmacol. 2015 Jan;8(1):95-102. doi: 10.1586/17512433.2015.992878. Review.

PMID:
25487079
14.

Global cardiovascular risk evaluation: pattern of algorithm use and risk modification in 'real life'.

Filippi A, Giampaoli S, Lapi F, Mazzaglia G, Palmieri L, Pecchioli S, Brignoli O, Cricelli C, Simonetti M, Sessa E, Marchioli R.

J Cardiovasc Med (Hagerstown). 2016 Aug;17(8):581-6. doi: 10.2459/JCM.0000000000000124.

PMID:
25347357
15.

Acne: in vivo morphologic study of lesions and surrounding skin by means of reflectance confocal microscopy.

Manfredini M, Mazzaglia G, Ciardo S, Farnetani F, Mandel VD, Longo C, Zauli S, Bettoli V, Virgili A, Pellacani G.

J Eur Acad Dermatol Venereol. 2015 May;29(5):933-9. doi: 10.1111/jdv.12730. Epub 2014 Sep 26.

PMID:
25255769
16.

Effects of a computerized decision support system in improving pharmacological management in high-risk cardiovascular patients: A cluster-randomized open-label controlled trial.

Mazzaglia G, Piccinni C, Filippi A, Sini G, Lapi F, Sessa E, Cricelli I, Cutroneo P, Trifirò G, Cricelli C, Caputi AP.

Health Informatics J. 2016 Jun;22(2):232-47. doi: 10.1177/1460458214546773. Epub 2014 Sep 10.

PMID:
25210009
17.

Systemic antibiotic prescribing to paediatric outpatients in 5 European countries: a population-based cohort study.

Holstiege J, Schink T, Molokhia M, Mazzaglia G, Innocenti F, Oteri A, Bezemer I, Poluzzi E, Puccini A, Ulrichsen SP, Sturkenboom MC, Trifirò G, Garbe E.

BMC Pediatr. 2014 Jul 5;14:174. doi: 10.1186/1471-2431-14-174.

18.

Effectiveness of oral bisphosphonates for primary prevention of osteoporotic fractures: evidence from the AIFA-BEST observational study.

Ghirardi A, Di Bari M, Zambon A, Scotti L, Della Vedova G, Lapi F, Cipriani F, Caputi AP, Vaccheri A, Gregori D, Gesuita R, Vestri A, Staniscia T, Mazzaglia G, Corrao G; BEST investigators.

Eur J Clin Pharmacol. 2014 Sep;70(9):1129-37. doi: 10.1007/s00228-014-1708-8. Epub 2014 Jun 22.

PMID:
24951915
19.

Risk of upper gastrointestinal bleeding from different drug combinations.

Masclee GM, Valkhoff VE, Coloma PM, de Ridder M, Romio S, Schuemie MJ, Herings R, Gini R, Mazzaglia G, Picelli G, Scotti L, Pedersen L, Kuipers EJ, van der Lei J, Sturkenboom MC.

Gastroenterology. 2014 Oct;147(4):784-792.e9; quiz e13-4. doi: 10.1053/j.gastro.2014.06.007. Epub 2014 Jun 14.

PMID:
24937265
20.

User-only design to assess drug effectiveness in clinical practice: application to bisphosphonates and secondary prevention of fractures.

Corrao G, Ghirardi A, Segafredo G, Zambon A, Della Vedova G, Lapi F, Cipriani F, Caputi A, Vaccheri A, Gregori D, Gesuita R, Vestri A, Staniscia T, Mazzaglia G, Di Bari M; BEST investigators.

Pharmacoepidemiol Drug Saf. 2014 Aug;23(8):859-67. doi: 10.1002/pds.3650. Epub 2014 Jun 9.

PMID:
24911392
21.

Signal detection of potentially drug-induced acute liver injury in children using a multi-country healthcare database network.

Ferrajolo C, Coloma PM, Verhamme KM, Schuemie MJ, de Bie S, Gini R, Herings R, Mazzaglia G, Picelli G, Giaquinto C, Scotti L, Avillach P, Pedersen L, Rossi F, Capuano A, van der Lei J, Trifiró G, Sturkenboom MC; EU-ADR consortium.

Drug Saf. 2014 Feb;37(2):99-108. doi: 10.1007/s40264-013-0132-9.

PMID:
24446276
22.

Oral bisphosphonates do not increase the risk of severe upper gastrointestinal complications: a nested case-control study.

Ghirardi A, Scotti L, Vedova GD, D'Oro LC, Lapi F, Cipriani F, Caputi AP, Vaccheri A, Gregori D, Gesuita R, Vestri A, Staniscia T, Mazzaglia G, Corrao G; AIFA-BEST Investigators.

BMC Gastroenterol. 2014 Jan 7;14:5. doi: 10.1186/1471-230X-14-5.

23.

Risk of severe upper gastrointestinal complications among oral bisphosphonate users.

Ghirardi A, Scotti L, Zambon A, Della Vedova G, Cavalieri D'oro L, Lapi F, Cipriani F, Caputi AP, Vaccheri A, Gregori D, Gesuita R, Vestri A, Staniscia T, Mazzaglia G, Corrao G; BEST Investigators.

PLoS One. 2013 Dec 9;8(12):e73159. doi: 10.1371/journal.pone.0073159. eCollection 2013.

24.

Replication of the OMOP experiment in Europe: evaluating methods for risk identification in electronic health record databases.

Schuemie MJ, Gini R, Coloma PM, Straatman H, Herings RM, Pedersen L, Innocenti F, Mazzaglia G, Picelli G, van der Lei J, Sturkenboom MC.

Drug Saf. 2013 Oct;36 Suppl 1:S159-69. doi: 10.1007/s40264-013-0109-8.

PMID:
24166232
25.

Drug-induced acute myocardial infarction: identifying 'prime suspects' from electronic healthcare records-based surveillance system.

Coloma PM, Schuemie MJ, Trifirò G, Furlong L, van Mulligen E, Bauer-Mehren A, Avillach P, Kors J, Sanz F, Mestres J, Oliveira JL, Boyer S, Helgee EA, Molokhia M, Matthews J, Prieto-Merino D, Gini R, Herings R, Mazzaglia G, Picelli G, Scotti L, Pedersen L, van der Lei J, Sturkenboom M; EU-ADR consortium.

PLoS One. 2013 Aug 28;8(8):e72148. doi: 10.1371/journal.pone.0072148. eCollection 2013. Erratum in: PLoS One. 2013;8(9). doi:10.1371/annotation/8824e161-bf8f-4f78-81e0-a62a1540276d.

26.

Burden of community-acquired pneumonia in Italian general practice.

Sterrantino C, Trifirò G, Lapi F, Pasqua A, Mazzaglia G, Piccinni C, Cricelli C, Rossi A, Blasi F.

Eur Respir J. 2013 Dec;42(6):1739-42. doi: 10.1183/09031936.00128713. Epub 2013 Aug 15. No abstract available.

27.

Identification of acute myocardial infarction from electronic healthcare records using different disease coding systems: a validation study in three European countries.

Coloma PM, Valkhoff VE, Mazzaglia G, Nielsson MS, Pedersen L, Molokhia M, Mosseveld M, Morabito P, Schuemie MJ, van der Lei J, Sturkenboom M, Trifirò G; EU-ADR Consortium.

BMJ Open. 2013 Jun 20;3(6). pii: e002862. doi: 10.1136/bmjopen-2013-002862.

28.

Cyclo-oxygenase-2 inhibitors or nonselective NSAIDs plus gastroprotective agents: what to prescribe in daily clinical practice?

Masclee GM, Valkhoff VE, van Soest EM, Schade R, Mazzaglia G, Molokhia M, Trifirò G, Goldstein JL, Hernández-Díaz S, Kuipers EJ, Sturkenboom MC.

Aliment Pharmacol Ther. 2013 Jul;38(2):178-89. doi: 10.1111/apt.12348. Epub 2013 May 28.

29.

Idiopathic acute liver injury in paediatric outpatients: incidence and signal detection in two European countries.

Ferrajolo C, Verhamme KM, Trifirò G, 't Jong GW, Giaquinto C, Picelli G, Oteri A, de Bie S, Valkhoff VE, Schuemie MJ, Mazzaglia G, Cricelli C, Rossi F, Capuano A, Sturkenboom MC.

Drug Saf. 2013 Oct;36(10):1007-16. doi: 10.1007/s40264-013-0045-7.

PMID:
23591830
30.

Does skin hydration influence keratinocyte biology? In vivo evaluation of microscopic skin changes induced by moisturizers by means of reflectance confocal microscopy.

Manfredini M, Mazzaglia G, Ciardo S, Simonazzi S, Farnetani F, Longo C, Pellacani G.

Skin Res Technol. 2013 Aug;19(3):299-307. doi: 10.1111/srt.12042. Epub 2013 Feb 26. Erratum in: Skin Res Technol. 2014 Aug;20(3):388. Marco, Manfredini [corrected to Manfredini, Marco]; Giovanna, Mazzaglia [corrected to Mazzaglia, Giovanna]; Silvana, Ciardo [corrected to Ciardo, Silvana]; Silvia, Simonazzi [corrected to Simonazzi, Silvia]; Francesca, Farnetani [corrected to Farnetani, Fr.

PMID:
23441646
31.

Chronic disease prevalence from Italian administrative databases in the VALORE project: a validation through comparison of population estimates with general practice databases and national survey.

Gini R, Francesconi P, Mazzaglia G, Cricelli I, Pasqua A, Gallina P, Brugaletta S, Donato D, Donatini A, Marini A, Zocchetti C, Cricelli C, Damiani G, Bellentani M, Sturkenboom MC, Schuemie MJ.

BMC Public Health. 2013 Jan 9;13:15. doi: 10.1186/1471-2458-13-15.

32.

Harmonization process for the identification of medical events in eight European healthcare databases: the experience from the EU-ADR project.

Avillach P, Coloma PM, Gini R, Schuemie M, Mougin F, Dufour JC, Mazzaglia G, Giaquinto C, Fornari C, Herings R, Molokhia M, Pedersen L, Fourrier-Réglat A, Fieschi M, Sturkenboom M, van der Lei J, Pariente A, Trifirò G; EU-ADR consortium.

J Am Med Inform Assoc. 2013 Jan 1;20(1):184-92. doi: 10.1136/amiajnl-2012-000933. Epub 2012 Sep 6.

33.

Using electronic health care records for drug safety signal detection: a comparative evaluation of statistical methods.

Schuemie MJ, Coloma PM, Straatman H, Herings RM, Trifirò G, Matthews JN, Prieto-Merino D, Molokhia M, Pedersen L, Gini R, Innocenti F, Mazzaglia G, Picelli G, Scotti L, van der Lei J, Sturkenboom MC.

Med Care. 2012 Oct;50(10):890-7.

PMID:
22929992
34.

Prescription of nonselective NSAIDs, coxibs and gastroprotective agents in the era of rofecoxib withdrawal - a 617,400-patient study.

Valkhoff VE, van Soest EM, Masclee GM, de Bie S, Mazzaglia G, Molokhia M, Kuipers EJ, Sturkenboom MC.

Aliment Pharmacol Ther. 2012 Oct;36(8):790-9. doi: 10.1111/apt.12028. Epub 2012 Aug 28.

35.

Epidemiology of gout and hyperuricaemia in Italy during the years 2005-2009: a nationwide population-based study.

Trifirò G, Morabito P, Cavagna L, Ferrajolo C, Pecchioli S, Simonetti M, Bianchini E, Medea G, Cricelli C, Caputi AP, Mazzaglia G.

Ann Rheum Dis. 2013 May;72(5):694-700. doi: 10.1136/annrheumdis-2011-201254. Epub 2012 Jun 26.

PMID:
22736095
36.

Proposal for an in vivo histopathologic scoring system for skin aging by means of confocal microscopy.

Longo C, Casari A, De Pace B, Simonazzi S, Mazzaglia G, Pellacani G.

Skin Res Technol. 2013 Feb;19(1):e167-73. doi: 10.1111/j.1600-0846.2012.00623.x. Epub 2012 Jun 7.

PMID:
22672873
37.

Assessing the risk of osteonecrosis of the jaw due to bisphosphonate therapy in the secondary prevention of osteoporotic fractures.

Lapi F, Cipriani F, Caputi AP, Corrao G, Vaccheri A, Sturkenboom MC, Di Bari M, Gregori D, Carle F, Staniscia T, Vestri A, Brandi M, Fusco V, Campisi G, Mazzaglia G; Bisphosphonates Efficacy-Safety Tradeoff (BEST) study group.

Osteoporos Int. 2013 Feb;24(2):697-705. doi: 10.1007/s00198-012-2013-y. Epub 2012 May 23.

PMID:
22618266
38.

Adherence to gastroprotection during cyclooxygenase 2 inhibitor treatment and the risk of upper gastrointestinal tract events: a population-based study.

Valkhoff VE, van Soest EM, Mazzaglia G, Molokhia M, Schade R, Trifiro G, Goldstein JL, Hernandez-Diaz S, Kuipers EJ, Sturkenboom MC.

Arthritis Rheum. 2012 Aug;64(8):2792-802. doi: 10.1002/art.34433.

39.

Electronic healthcare databases for active drug safety surveillance: is there enough leverage?

Coloma PM, Trifirò G, Schuemie MJ, Gini R, Herings R, Hippisley-Cox J, Mazzaglia G, Picelli G, Corrao G, Pedersen L, van der Lei J, Sturkenboom M; EU-ADR Consortium.

Pharmacoepidemiol Drug Saf. 2012 Jun;21(6):611-21. doi: 10.1002/pds.3197. Epub 2012 Feb 8.

PMID:
22315152
40.

Risk of cardiac valve regurgitation with dopamine agonist use in Parkinson's disease and hyperprolactinaemia: a multi-country, nested case-control study.

Trifirò G, Mokhles MM, Dieleman JP, van Soest EM, Verhamme K, Mazzaglia G, Herings R, de Luise C, Ross D, Brusselle G, Colao A, Haverkamp W, Schade R, van Camp G, Zanettini R, Sturkenboom MC.

Drug Saf. 2012 Feb 1;35(2):159-71. doi: 10.2165/11594940-000000000-00000.

PMID:
22204718
41.

The risk of new onset heart failure associated with dopamine agonist use in Parkinson's disease.

Mokhles MM, Trifirò G, Dieleman JP, Haag MD, van Soest EM, Verhamme KM, Mazzaglia G, Herings R, Luise Cd, Ross D, Brusselle G, Colao A, Haverkamp W, Schade R, Camp Gv, Zanettini R, Sturkenboom MC.

Pharmacol Res. 2012 Mar;65(3):358-64. doi: 10.1016/j.phrs.2011.11.009. Epub 2011 Nov 23.

PMID:
22123498
42.

Assessing 5-year incidence rates and determinants of osteoporotic fractures in primary care.

Lapi F, Simonetti M, Michieli R, Pasqua A, Brandi ML, Frediani B, Cricelli C, Mazzaglia G.

Bone. 2012 Jan;50(1):85-90. doi: 10.1016/j.bone.2011.09.048. Epub 2011 Oct 2.

PMID:
21985999
43.

Effect of removing an impacted mandibular third molar on the periodontal status of the mandibular second molar.

Montero J, Mazzaglia G.

J Oral Maxillofac Surg. 2011 Nov;69(11):2691-7. doi: 10.1016/j.joms.2011.06.205. Epub 2011 Aug 23.

PMID:
21864969
44.

EU-ADR healthcare database network vs. spontaneous reporting system database: preliminary comparison of signal detection.

Trifirò G, Patadia V, Schuemie MJ, Coloma PM, Gini R, Herings R, Hippisley-Cox J, Mazzaglia G, Giaquinto C, Scotti L, Pedersen L, Avillach P, Sturkenboom MC, van der Lei J, Eu-Adr Group.

Stud Health Technol Inform. 2011;166:25-30.

PMID:
21685607
45.

Suboptimal gastroprotective coverage of NSAID use and the risk of upper gastrointestinal bleeding and ulcers: an observational study using three European databases.

van Soest EM, Valkhoff VE, Mazzaglia G, Schade R, Molokhia M, Goldstein JL, Hernández-Díaz S, Trifirò G, Dieleman JP, Kuipers EJ, Sturkenboom MC.

Gut. 2011 Dec;60(12):1650-9. doi: 10.1136/gut.2011.239848. Epub 2011 Jun 2.

PMID:
21636644
46.

A national survey on aspirin patterns of use and persistence in community outpatients in Italy.

Filippi A, Bianchi C, Parazzini F, Cricelli C, Sessa E, Mazzaglia G.

Eur J Cardiovasc Prev Rehabil. 2011 Oct;18(5):695-703. doi: 10.1177/1741826710397850. Epub 2011 Mar 1.

PMID:
21450601
47.

Combining electronic healthcare databases in Europe to allow for large-scale drug safety monitoring: the EU-ADR Project.

Coloma PM, Schuemie MJ, Trifirò G, Gini R, Herings R, Hippisley-Cox J, Mazzaglia G, Giaquinto C, Corrao G, Pedersen L, van der Lei J, Sturkenboom M; EU-ADR Consortium.

Pharmacoepidemiol Drug Saf. 2011 Jan;20(1):1-11. doi: 10.1002/pds.2053. Epub 2010 Nov 8.

PMID:
21182150
48.

Design and evaluation of a semantic approach for the homogeneous identification of events in eight patient databases: a contribution to the European EU-ADR project.

Avillach P, Joubert M, Thiessard F, Trifirò G, Dufour JC, Pariente A, Mougin F, Polimeni G, Catania MA, Giaquinto C, Mazzaglia G, Fornari C, Herings R, Gini R, Hippisley-Cox J, Molokhia M, Pedersen L, Fourrier-Réglat A, Sturkenboom M, Fieschi M.

Stud Health Technol Inform. 2010;160(Pt 2):1085-9.

PMID:
20841851
49.

Venous thromboembolism in medical patients treated in the setting of primary care: a nationwide case-control study in Italy.

Cimminiello C, Filippi A, Mazzaglia G, Pecchioli S, Arpaia G, Cricelli C.

Thromb Res. 2010 Nov;126(5):367-72. doi: 10.1016/j.thromres.2010.07.005. Epub 2010 Aug 14.

PMID:
20709364
50.

Safety profile of the fluoroquinolones: analysis of adverse drug reactions in relation to prescription data using four regional pharmacovigilance databases in Italy.

Lapi F, Tuccori M, Motola D, Pugi A, Vietri M, Montanaro N, Vaccheri A, Leoni O, Cocci A, Leone R, Conforti A, Moretti U, Sessa E, Mazzaglia G, Mugelli A, Mazzei T, Vannacci A.

Drug Saf. 2010 Sep 1;33(9):789-99. doi: 10.2165/11536810-000000000-00000.

PMID:
20701411

Supplemental Content

Loading ...
Support Center